Evidence map›Paper›PMID 36339118›Full record

ReviewJACC. Asia2022

Percutaneous Coronary Intervention for Left Main Coronary Artery Disease: Present Status and Future Perspectives.

Sangwoo Park, Seung-Jung Park, Duk-Woo Park

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in JACC. Asia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. OCT-Guided Distal Left Main Bifurcation PCI: Mid-Term Outcomes From a Multicenter South-Asian Registry.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Observational
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. [Clinical outcomes of percutaneous intervention on the unprotected left main coronary artery].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sangwoo ParkDepartment of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
Seung-Jung ParkDepartment of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Duk-Woo ParkDepartment of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For several decades, coronary artery bypass grafting has been regarded as the standard choice of revascularization for significant left main coronary artery (LMCA) disease. However, in conjunction with remarkable advancement of device technology and adjunctive pharmacology, percutaneous coronary intervention (PCI) offers a more expeditious approach with rapid recovery and is a safe and effective alternative in appropriately selected patients with LMCA disease. Several landmark randomized clinical trials showed that PCI with drug-eluting stents for LMCA disease is a safe option with similar long-term survival rates to coronary artery bypass grafting surgery, especially in those with low and intermediate anatomic risk. Although it is expected that the updated evidence from recent randomized clinical trials will determine the next guidelines for the foreseeable future, there are still unresolved and unmet issues of LMCA revascularization and PCI strategy. This paper provides a comprehensive review on the evolution and an update on the management of LMCA disease.

Indexed as

BMS, bare-metal stent(s)CABG, coronary artery bypass graftingCAD, coronary artery diseasecoronary artery bypass graftingDAPT, dual antiplatelet therapyDES, drug-eluting stent(s)DK, double-kissingFFR, fractional flow reserveiFR, instantaneous wave-free ratioIVUS, intravascular ultrasoundLAD, left anterior descending arteryLCX, left circumflex arteryleft main coronary artery diseaseLMCA, left main coronary arteryLVEF, left ventricular ejection fractionMACCE, major adverse cardiac or cerebrovascular eventsMI, myocardial infarctionMLA, minimal lumen areaPCI, percutaneous coronary interventionpercutaneous coronary interventionRCT, randomized clinical trial

Identifiers

PMID36339118
PMCPMC9627854

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.